Skip to main content
Premium Trial:

Request an Annual Quote

FEI and MPI to Improve Electron Tomography as Part of EU Proteomics Project

NEW YORK, April 26 (GenomeWeb News) - FEI will collaborate with researchers at the Max Planck Institute of Biochemistry in Martinsried to develop new electron tomography technology for studying protein complexes in cells, the company said today.


The collaboration is part of a large-scale interaction proteomics project funded with 12 million from the European Union. Electron microscope maker FEI, of Eindhoven, the Netherlands, will receive about 700,000 ($830,000) of the funding for the first 18 months, according to Ulrich Hartl, a professor and director at MPI Martinsried who coordinates the project.


The project, which has nine academic partners in several European countries, also includes Thermo Electron in Bremen, Germany, and protein array firm Jerini of Berlin. More details can be found in this week's ProteoMonitor.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.